Noone, J.; Rooney, M.F.; Karavyraki, M.; Yates, A.; O’Sullivan, S.E.; Porter, R.K.
Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro. Pharmaceuticals 2023, 16, 1580.
https://doi.org/10.3390/ph16111580
AMA Style
Noone J, Rooney MF, Karavyraki M, Yates A, O’Sullivan SE, Porter RK.
Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro. Pharmaceuticals. 2023; 16(11):1580.
https://doi.org/10.3390/ph16111580
Chicago/Turabian Style
Noone, John, Mary F. Rooney, Marilena Karavyraki, Andrew Yates, Saoirse E. O’Sullivan, and Richard K. Porter.
2023. "Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro" Pharmaceuticals 16, no. 11: 1580.
https://doi.org/10.3390/ph16111580
APA Style
Noone, J., Rooney, M. F., Karavyraki, M., Yates, A., O’Sullivan, S. E., & Porter, R. K.
(2023). Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro. Pharmaceuticals, 16(11), 1580.
https://doi.org/10.3390/ph16111580